Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with ADHD

Friday, October 21, 2011

Ann C. Childress, M.D., Center for Psychiatry and Behavioral Medicine, Las Vegas, NV

Andrew Cutler, M.D., Florida Clinical Research Center, LLC, Bradenton, FL

Keith Saylor, Ph.D., NeuroScience, Inc., Herndon, VA

Maria Gasior, M.D., Ph.D., Shire Pharmaceuticals Inc., Wayne, PA

Mohamed Hamdani, M.S., Shire Development Inc., Wane, PA

M. Celeste Ferreira-Cornwell, Ph.D., Shire Development Inc., Wayne, PA

Robert L. Findling, M.D., Psychiatry, University Hospitals Case Medical Center, Cleveland, OH


Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 4.19 Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with ADHD